FDA Inspection 1122522 — Charles River Laboratories Cleveland, Inc.
The FDA completed an inspection of Charles River Laboratories Cleveland, Inc. on February 19, 2020 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 19, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cleveland, OH (United States)